These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 12817887)

  • 21. A study of the intestinal absorption of an ester-type prodrug, ME3229, in rats: active efflux transport as a cause of poor bioavailability of the active drug.
    Okudaira N; Tatebayashi T; Speirs GC; Komiya I; Sugiyama Y
    J Pharmacol Exp Ther; 2000 Aug; 294(2):580-7. PubMed ID: 10900235
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fosphenytoin: clinical pharmacokinetics and comparative advantages in the acute treatment of seizures.
    Fischer JH; Patel TV; Fischer PA
    Clin Pharmacokinet; 2003; 42(1):33-58. PubMed ID: 12489978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhancing the intestinal membrane permeability of zanamivir: a carrier mediated prodrug approach.
    Gupta SV; Gupta D; Sun J; Dahan A; Tsume Y; Hilfinger J; Lee KD; Amidon GL
    Mol Pharm; 2011 Dec; 8(6):2358-67. PubMed ID: 21905667
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 5'-Amino acid esters of antiviral nucleosides, acyclovir, and AZT are absorbed by the intestinal PEPT1 peptide transporter.
    Han H; de Vrueh RL; Rhie JK; Covitz KM; Smith PL; Lee CP; Oh DM; Sadée W; Amidon GL
    Pharm Res; 1998 Aug; 15(8):1154-9. PubMed ID: 9706043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Morpholinoalkyl ester prodrugs of diclofenac: synthesis, in vitro and in vivo evaluation.
    Tammara VK; Narurkar MM; Crider AM; Khan MA
    J Pharm Sci; 1994 May; 83(5):644-8. PubMed ID: 8071813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bioavailability and anticonvulsant activity of a monoglyceride-derived prodrug of phenytoin after oral administration to rats.
    Scriba GK; Lambert DM; Poupaert JH
    J Pharm Sci; 1995 Mar; 84(3):300-2. PubMed ID: 7616367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intestinal absorption and activation of decitabine amino acid ester prodrugs mediated by peptide transporter PEPT1 and enterocyte enzymes.
    Tao W; Zhao D; Sun M; Wang Z; Lin B; Bao Y; Li Y; He Z; Sun Y; Sun J
    Int J Pharm; 2018 Apr; 541(1-2):64-71. PubMed ID: 29471144
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of water-soluble prodrugs of the HIV-1 protease inhibitor KNI-727: importance of the conversion time for higher gastrointestinal absorption of prodrugs based on spontaneous chemical cleavage.
    Sohma Y; Hayashi Y; Ito T; Matsumoto H; Kimura T; Kiso Y
    J Med Chem; 2003 Sep; 46(19):4124-35. PubMed ID: 12954064
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phenytoin prodrugs III: water-soluble prodrugs for oral and/or parenteral use.
    Varia SA; Schuller S; Sloan KB; Stella VJ
    J Pharm Sci; 1984 Aug; 73(8):1068-73. PubMed ID: 6491911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Passive and carrier-mediated intestinal absorption components of two angiotensin converting enzyme (ACE) inhibitor prodrugs in rats: enalapril and fosinopril.
    Friedman DI; Amidon GL
    Pharm Res; 1989 Dec; 6(12):1043-7. PubMed ID: 2560181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intestinal absorption of novel-dipeptide prodrugs of saquinavir in rats.
    Jain R; Duvvuri S; Kansara V; Mandava NK; Mitra AK
    Int J Pharm; 2007 May; 336(2):233-40. PubMed ID: 17207946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel prodrug approach for tertiary amines. 3. In vivo evaluation of two N-phosphonooxymethyl prodrugs in rats and dogs.
    Krise JP; Charman WN; Charman SA; Stella VJ
    J Pharm Sci; 1999 Sep; 88(9):928-32. PubMed ID: 10479356
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phenytoin pharmacokinetics following oral administration of phenytoin suspension and fosphenytoin solution to rats.
    Burstein AH; Cox DS; Mistry B; Eddington ND
    Epilepsy Res; 1999 Apr; 34(2-3):129-33. PubMed ID: 10210027
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of intestinal first-pass hydrolysis on the oral bioavailability of an ester prodrug of fexofenadine.
    Ohura K; Soejima T; Nogata R; Adachi Y; Ninomiya S; Imai T
    J Pharm Sci; 2012 Sep; 101(9):3264-74. PubMed ID: 22628163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Physiological models are good tools to predict rat bioavailability of EF5154 prodrugs from in vitro intestinal parameters.
    Nomoto M; Tatebayashi T; Morita J; Suzuki H; Aizawa K; Kurosawa T; Komiya I
    J Pharm Sci; 2009 Apr; 98(4):1532-44. PubMed ID: 18683862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Propylene glycol-linked amino acid/dipeptide diester prodrugs of oleanolic acid for PepT1-mediated transport: synthesis, intestinal permeability, and pharmacokinetics.
    Cao F; Gao Y; Wang M; Fang L; Ping Q
    Mol Pharm; 2013 Apr; 10(4):1378-87. PubMed ID: 23339520
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fosphenytoin: a novel phenytoin prodrug.
    Boucher BA
    Pharmacotherapy; 1996; 16(5):777-91. PubMed ID: 8888074
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral absorption of 21-corticosteroid esters: a function of aqueous stability and intestinal enzyme activity and distribution.
    Fleisher D; Johnson KC; Stewart BH; Amidon GL
    J Pharm Sci; 1986 Oct; 75(10):934-9. PubMed ID: 3795022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction of dipeptide prodrugs of saquinavir with multidrug resistance protein-2 (MRP-2): evasion of MRP-2 mediated efflux.
    Jain R; Agarwal S; Mandava NK; Sheng Y; Mitra AK
    Int J Pharm; 2008 Oct; 362(1-2):44-51. PubMed ID: 18620036
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anticonvulsant effect of fosphenytoin in amygdala-kindled rats: comparison with phenytoin.
    Löscher W; Reissmüller E; Ebert U
    Epilepsy Res; 1998 Mar; 30(1):69-76. PubMed ID: 9551846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.